alexa Cara J. Westmark | University of Wisconsin-Madison, Wai
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Cara J. Westmark

Cara J. Westmark Cara J. Westmark
Department of Pathology & Laboratory Medicine
University of Wisconsin-Madison
Waisman Center for Developmental Disabilities
USA
Tel: 608-262-9730
Biography

Dr. Cara Westmark is an Associate Scientist at the Waisman Center for Developmental Disabilities at the University of Wisconsin-Madison. Her current research examines the role of genetic and environmental factors on the expression of amyloid precursor protein (APP) and beta-amyloid (A beta) in transgenic mouse models of neurological disorders. She has demonstrated that APP/ A beta levels are altered in Fragile X syndrome and that many FXS phenotypes can be rescued in a mouse model of the disorder by genetically reducing APP/ A beta. These data suggest that therapies studied for the treatment of Alzheimer’s disease (AD) may be beneficial in the treatment of FXS. She has also demonstrated a strong association between APP/ A beta over-expression and lower seizure threshold, which has important implications for the treatment of seizure-related disorders such as AD, FXS and Down syndrome. Her most recent work has demonstrated a strong association between dietary phytoestrogen consumption, elevated A beta and reduced seizure threshold.

Research Interest

Cara current research examines the role of genetic and environmental factors on the expression of amyloid precursor protein (APP) and beta-amyloid (A Beta) in transgenic mouse models of neurological disorders.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Effect of Anticoagulants on Amyloid®-Protein Precursor and Amyloid Beta Levels in Plasma
Cara J. Westmark, Crystal M. Hervey, Elizabeth M. Berry-Kravisc, and James S. Maltera
Rapid Communication: J Alzheimers Dis 2011, 1:101
DOI: 10.4172/2161-0460.1000101
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords